effacnyl

Cosmetic recorded by Open Beauty Facts contributors

Brand

Cliniceutica

EAN-13

0627987220070

Quantity

50 ml

Sales countries

Maroc

Record created on

17 June 2022

• Open Beauty Facts record: photos, edit history
• Correct the Open Beauty Facts record
• All products from the brand: Cliniceutica

Fiche 0627987220070. Open Beauty Facts, export of cosmetic products, retrieved 23 October 2026.

Data “Open Beauty Facts and its contributors”, licensed under ODbL 1.0 (opendatacommons.org/licenses/odbl/1-0); derived table distributed under the same licence.

Packaging photo dated 17 June 2022 (Automatic transcriptions of Open Beauty Facts ingredient-list photos (two AI readings, checked by text recognition)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Points to note

Findings according to the 2022 list.

None of the names read is prohibited in all cases in European Union cosmetics; the transcribed list may be incomplete.

Who it concerns

For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.

Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.

• Pregnancy and breastfeeding

  • Worth watching Salicylic AcidClassified under the CLP Regulation: reproductive toxicity, category 2 (Repr. 2), a hazard to the unborn child. The European Union nevertheless allows it under the conditions of its annex, after an opinion of its Scientific Committee on Consumer Safety (SCCS).

• Babies and children

  • Prohibition or serious classification Salicylic AcidAnnex III, entry 98, prohibits it in products intended for children under 3: “Not to be used in preparations for children under 3 years of age.” Annex V, entry 3, prohibits it in products intended for children under 3: “Not to be used in products for children under 3 years of age.”

• Skin, eyes and allergies

  • For information Salicylic AcidClassified under the CLP Regulation: serious eye damage, category 1 (Eye Dam. 1). This classification describes the pure substance; in a finished product it is far more diluted.
  • For information Potassium SorbateClassified under the CLP Regulation: eye irritation, category 2 (Eye Irrit. 2). This classification describes the pure substance; in a finished product it is far more diluted.

• Read on the label

  • For information Salicylic AcidAnnex III, entry 98, requires this to be printed on the pack: “(a) (b) (c) Not to be used for children under 3 years of age* * Solely for products which might be used for children under 3 years of age.”. Annex V, entry 3, requires this to be printed on the pack: “Salicylic acid: Not to be used for children under 3 years of age** **Solely for products which might be used for children under 3 years of age. Salicylic acid salts: Not to be used for children under 3 years of age*** ***Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.”.

No official text covers the recognised ingredients for: environment.

For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.

Recorded composition

23 recognised ingredients out of 23.

Hover over or tap a badge for its meaning.

Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.